KemPharm Inc Annual Meeting of Stockholders
May 24, 2016 from 9:00 AM to 9:00 AM EDT
Harvard Club of New York City
Gordon Reading Room
KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.